These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
479 related items for PubMed ID: 12743157
1. Treatment of intraocular retinoblastoma with vincristine and carboplatin. Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB. J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157 [Abstract] [Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct 15; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
3. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C. Am J Ophthalmol; 2005 Sep 15; 140(3):397-406. PubMed ID: 16138999 [Abstract] [Full Text] [Related]
4. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT. J Clin Oncol; 2000 Jan 15; 18(1):12-7. PubMed ID: 10623688 [Abstract] [Full Text] [Related]
5. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S. Pediatr Blood Cancer; 2008 Mar 15; 50(3):567-72. PubMed ID: 17729249 [Abstract] [Full Text] [Related]
6. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ. Am J Ophthalmol; 2002 May 15; 133(5):657-64. PubMed ID: 11992863 [Abstract] [Full Text] [Related]
7. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP, Honavar SG, Reddy VA, Khanna R. Ophthalmology; 2014 Feb 15; 121(2):517-24. PubMed ID: 24572675 [Abstract] [Full Text] [Related]
8. Chemoreduction for unilateral retinoblastoma. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Arch Ophthalmol; 2002 Dec 15; 120(12):1653-8. PubMed ID: 12470138 [Abstract] [Full Text] [Related]
9. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG. Arch Ophthalmol; 2003 Jul 15; 121(7):979-84. PubMed ID: 12860801 [Abstract] [Full Text] [Related]
10. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT. Ophthalmology; 1997 Dec 15; 104(12):2101-11. PubMed ID: 9400771 [Abstract] [Full Text] [Related]
11. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Wilson MW, Rodriguez-Galindo C, Haik BG, Moshfeghi DM, Merchant TE, Pratt CB. Ophthalmology; 2001 Nov 15; 108(11):2106-14; discussion 2114-5. PubMed ID: 11713087 [Abstract] [Full Text] [Related]
12. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma. Brennan RC, Qaddoumi I, Mao S, Wu J, Billups CA, Stewart CF, Hoehn ME, Rodriguez-Galindo C, Wilson MW. J Clin Oncol; 2017 Jan 15; 35(1):72-77. PubMed ID: 28034080 [Abstract] [Full Text] [Related]
14. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M. Arch Ophthalmol; 1998 Dec 15; 116(12):1613-7. PubMed ID: 9869790 [Abstract] [Full Text] [Related]
15. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Ophthalmology; 2007 Jan 15; 114(1):162-9. PubMed ID: 17070578 [Abstract] [Full Text] [Related]
16. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH. Br J Ophthalmol; 2013 Oct 15; 97(10):1277-83. PubMed ID: 23863458 [Abstract] [Full Text] [Related]
17. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Demirci H, Eagle RC, Shields CL, Shields JA. Arch Ophthalmol; 2003 Aug 15; 121(8):1125-31. PubMed ID: 12912690 [Abstract] [Full Text] [Related]
18. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. Beck MN, Balmer A, Dessing C, Pica A, Munier F. J Clin Oncol; 2000 Aug 15; 18(15):2881-7. PubMed ID: 10920136 [Abstract] [Full Text] [Related]
19. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma]. Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A. Med Wieku Rozwoj; 2001 Aug 15; 5(3 Suppl 1):15-23. PubMed ID: 12004148 [Abstract] [Full Text] [Related]
20. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar 15; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]